about
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified ...
Read More517.5K XNAS Volume
XNAS 06 Jun, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for IN8bio Inc is on 12 Jun 2025 for the purpose of IN8bio Inc Annual General Meeting for 2025
See details
Not Eligible
Expensive Valuation
Technically Bullish
IN8bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..